|
Volumn 23, Issue 3, 2014, Pages 580-582
|
Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant
|
Author keywords
Acute ischemic stroke; cardiogenic embolism; novel oral anticoagulants; thrombolytic treatment
|
Indexed keywords
ACENOCOUMAROL;
BIOLOGICAL MARKER;
DABIGATRAN;
ADULT;
ANTICOAGULANT THERAPY;
ARTICLE;
BASAL GANGLION;
BLOOD CLOT LYSIS;
BLOOD CLOTTING TEST;
BRAIN ISCHEMIA;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
FOLLOW UP;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
MALE;
MIDDLE AGED;
NEUROIMAGING;
PARTIAL THROMBOPLASTIN TIME;
PRIORITY JOURNAL;
THROMBIN TIME;
ACUTE ISCHEMIC STROKE;
CARDIOGENIC EMBOLISM;
NOVEL ORAL ANTICOAGULANTS;
THROMBOLYTIC TREATMENT;
ADMINISTRATION, ORAL;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
BENZIMIDAZOLES;
BETA-ALANINE;
BLOOD COAGULATION;
BRAIN ISCHEMIA;
FIBRINOLYTIC AGENTS;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MIDDLE AGED;
PARTIAL THROMBOPLASTIN TIME;
PATIENT SELECTION;
PREDICTIVE VALUE OF TESTS;
RISK ASSESSMENT;
RISK FACTORS;
STROKE;
THROMBIN TIME;
THROMBOLYTIC THERAPY;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84896323323
PISSN: 10523057
EISSN: 15328511
Source Type: Journal
DOI: 10.1016/j.jstrokecerebrovasdis.2013.04.029 Document Type: Article |
Times cited : (6)
|
References (9)
|